Trials / Recruiting
RecruitingNCT06086132
Detection and Prevention of Cancer-Related Cardiovascular Toxicity Registry
Detection and Prevention of Cancer-Related Cardiovascular Toxicity Registry (ISACS CARDIONCO-PREDICT)
- Status
- Recruiting
- Phase
- —
- Study type
- Observational
- Enrollment
- 10,000 (estimated)
- Sponsor
- University of Bologna · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This study is being done in order to assess the cardiovascular events known as cardiovascular toxicity of chemotherapy agents and radiotherapy protocols in cancer subjects to identify risk prediction, prevention and treatment of cancer therapy-related cardiovascular toxicity and cancer therapy-related cardiac dysfunction
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| COMBINATION_PRODUCT | Prospective validation of the HFA-ICOS risk score in a subset of subjects with newly diagnosed breast cancer and undergoing treatment with anthracyclines analogues with or without radiotherapy | Follow-up visits at baseline, 3-months, and 1-year |
Timeline
- Start date
- 2025-05-01
- Primary completion
- 2026-12-31
- Completion
- 2026-12-31
- First posted
- 2023-10-17
- Last updated
- 2025-06-19
Locations
5 sites across 3 countries: Italy, North Macedonia, Serbia
Source: ClinicalTrials.gov record NCT06086132. Inclusion in this directory is not an endorsement.